A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis.
Coto-Segura P, Segú-Vergés C, Martorell A, Moreno-Ramírez D, Jorba G, Junet V, Guerri F, Daura X, Oliva B, Cara C, Suárez-Magdalena O, Abraham S, Mas JM.
Coto-Segura P, et al. Among authors: cara c.
Front Immunol. 2023 Sep 20;14:1212981. doi: 10.3389/fimmu.2023.1212981. eCollection 2023.
Front Immunol. 2023.
PMID: 37809085
Free PMC article.